Cresanto Global P/B Ratio

Current P/B Ratio
-0.7
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity

Cresanto Global (CRESANTO) P/B ratio is -0.7 (Low), book value per share ₹-7.50 vs Healthcare average P/B of -0.22 — Very Low - Significant discount to book value, potential distress or value opportunity. Review CRESANTO P/E ratio to evaluate earnings-based valuation against sector peers.

Current Valuation Metrics

P/B Ratio -0.7
Current Price ₹4.88
Book Value/Share ₹-7.50
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹-3 Cr
Share Capital ₹4 Cr
Reserves & Surplus ₹-7 Cr
Outstanding Shares 4,000,000
Book Value per Share ₹-7.50

Valuation Signal

Signal Undervalued

Sector Context

Sector Average -0.22
Sector Median 0.55
Sector Rank #8 of 50
Sector Percentile 16.0%

CRESANTO P/B Ratio — Valuation Insights & Book Value Analysis

Cresanto Global price-to-book ratio interpretation, valuation status and historical context — current P/B -0.7 (Low). For live price, earnings yield and the full fundamental profile, see Cresanto Global screener.

  • Stock appears undervalued with PB of -0.7, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at discount to sector average PB of -0.22

CRESANTO vs Healthcare Peers — P/B Ratio Comparison

Cresanto Global P/B -0.7 vs Healthcare average -0.22, median 0.55 — range -12.29–1.1.

Sector Average
-0.22
Sector Median
0.55
Lowest P/B
-12.29
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -12.29 ₹15 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.6 ₹38 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.04 ₹66 Low
Krebs Biochemicals & Ind… KREBSBIO -0.7 ₹116 Low
Vivimed Labs VIVIMEDLAB -0.17 ₹41 Low
Triochem Products TRIPR 0.04 ₹0 Low